FDA 483 - Farinelli Enterprises - March 02, 2023

Farinelli Enterprises, a dealer in Le Grand, CA, was cited for two observations during an FDA inspection. The firm offered a food-producing goat for interstate commerce that contained an illegal drug residue (oxytetracycline) in its edible tissue. Additionally, the firm failed to identify the animal or maintain records of its purchase, hindering the investigation into the drug's administration.